Steve joined Advent in 2015, and brings 20 years of executive leadership experience in both small biotech and larger pharmaceutical companies in the UK, Japan, and Scandinavia.
He has a strong track record of R&D expertise in pre-clinical drug discovery as well as business development and corporate responsibilities. Steve was most recently COO of Coco Therapeutics and prior to that, COO and VP Corporate Development at Topotarget A/S in Copenhagen.
Steve is originally a pharmacologist with a PhD from the University of Southampton.
Steve plays a key role in Advent’s diligence into pre-clinical small molecule programs, and has been an advisor to several investee companies including Artax.
Assistant Bonita Theara
E. Bonita.Theara@adventls.com
T. +44 (0)20 7932 2157
